TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PeakRemedy AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
45
|
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
0
|
-1
|
-11 |
EBITDA |
0
|
-1
|
-11 |
Total assets |
9
|
29
|
196 |
Current assets |
9
|
29
|
196 |
Current liabilities |
4
|
0
![]() |
0 |
Equity capital |
5
|
14
|
180 |
- share capital |
5
|
4
|
5 |
Employees (average) |
1
|
0
|
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
55.6%
|
48.3%
|
91.8% |
Turnover per employee | 45 | 0 | |
Profit as a percentage of turnover | 0% | ||
Return on assets (ROA) |
0%
|
-3.4%
|
-5.6% |
Current ratio | 225.0% | ||
Return on equity (ROE) |
0%
|
-7.1%
|
-6.1% |
Change turnover |
45
|
0
|
-516 |
Change turnover % | -100% | ||
Chg. No. of employees |
1
|
-1
|
-6 |
Chg. No. of employees % |
-100%
|
-86% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.